Passa al contenuto
Merck

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway.

European journal of immunology (2014-08-19)
Catalin Koro, Ewa Bielecka, Anders Dahl-Knudsen, Jan J Enghild, Carsten Scavenius, Johan G Brun, Veronika Binder, Annelie Hellvard, Brith Bergum, Roland Jonsson, Jan Potempa, Anna M Blom, Piotr Mydel
ABSTRACT

Post-translational modifications of proteins significantly affect their structure and function. The carbamylation of positively charged lysine residues to form neutral homoitrulline occurs primarily under inflammatory conditions through myeloperoxidase-dependent cyanate (CNO-) formation. We analyzed the pattern of human IgG1 carbamylation under inflammatory conditions and the effects that this modification has on the ability of antibodies to trigger complement activation via the classical pathway. We found that the lysine residues of IgG1 are rapidly modified after brief exposure to CNO- . Interestingly, modifications were not random, but instead limited to only few lysines within the hinge area and the N-terminal fragment of the CH2 domain. A complement activation assay combined with mass spectrometry analysis revealed a highly significant inverse correlation between carbamylation of several key lysine residues within the hinge region and N-terminus of the CH2 domain and the proper binding of C1q to human IgG1 followed by subsequent complement activation. This severely hindered complement-dependent cytotoxicity of therapeutic IgG1 . The reaction can apparently occur in vivo, as we found carbamylated antibodies in synovial fluid from rheumatoid arthritis patients. Taken together, our data suggest that carbamylation has a profound impact on the complement-activating ability of IgG1 and reveals a pivotal role for previously uncharacterized lysine residues in this process.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Acido solforico, ACS reagent, 95.0-98.0%
Sigma-Aldrich
Acido formico, reagent grade, ≥95%
Sigma-Aldrich
Acido fosforico, ACS reagent, ≥85 wt. % in H2O
Sigma-Aldrich
Acido formico, ACS reagent, ≥96%
Sigma-Aldrich
Acido fosforico, 85 wt. % in H2O, 99.99% trace metals basis
Sigma-Aldrich
Acido fosforico, ACS reagent, ≥85 wt. % in H2O
Sigma-Aldrich
Iodoacetamide, Single use vial of 56 mg
Sigma-Aldrich
Iodoacetamide, BioUltra
Sigma-Aldrich
DL-Dithiothreitol solution, BioUltra, for molecular biology, ~1 M in H2O
Sigma-Aldrich
Acido solforico, 99.999%
Supelco
DL-Dithiothreitol solution, 1 M in H2O
Sigma-Aldrich
Acido fosforico, crystalline, ≥99.999% trace metals basis
Sigma-Aldrich
Iodoacetamide, ≥99% (NMR), crystalline
Sigma-Aldrich
Acido formico, ACS reagent, ≥88%
Sigma-Aldrich
o-Phenylenediamine, flaked, 99.5%
Sigma-Aldrich
Acido fosforico, 85 wt. % in H2O, FCC, FG
Sigma-Aldrich
Acido fenilacetico, 99%
Sigma-Aldrich
Acido fosforico, BioUltra, ≥85% (T)
Sigma-Aldrich
2,3-Butanedione monoxime, ≥98%
Sigma-Aldrich
Cadmium sulfate, ACS reagent, ≥99.0%
Sigma-Aldrich
Thiosemicarbazide, 99%
Sigma-Aldrich
o-Phenylenediamine, Peroxidase substrate, ≥98.0%, powder
Sigma-Aldrich
Acido formico, ≥95%, FCC, FG
Sigma-Aldrich
Acido fosforico, ≥85 wt. % in H2O, ≥99.999% trace metals basis
Sigma-Aldrich
Acido fenilacetico, ≥99%, FCC, FG
Sigma-Aldrich
Acido fosforico, BioReagent, suitable for insect cell culture, 85%
SAFC
Iodoacetamide
Supelco
Acido solforico, 0.1 M H2SO4 in water (0.2N), eluent concentrate for IC
Sigma-Aldrich
o-Phenylenediamine, tablet, 20 mg substrate per tablet
Sigma-Aldrich
o-Phenylenediamine, sublimed, ≥99%